Abstract
Policy question
Should CHIK-VLP be recommended for use in persons aged ≥12 years traveling to areas with risk of chikungunya virus transmission
Background paper
Americas
United States of America
EtR framework
Chikungunya
Resources
/
NITAG documentation
Evidence to Recommendations and proposed recommendations for use of virus-like particle chikungunya vaccine among adolescent and adult travelers
Download:
